Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Globus Medical Inc (NY: GMED )

84.34 -0.56 (-0.67%)
Streaming Delayed Price Updated: 3:02 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical Inc

< Previous 1 2 3 4 5 6 7 Next >
Globus Medical (GMED) Q4 2022 Earnings Call Transcript
GMED earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Globus Medical Reports Fourth Quarter and Full Year 2022 Results
From Globus Medical
Via GlobeNewswire
Globus Medical Earnings Preview
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
Via Benzinga
6 Analysts Have This to Say About Globus Medical
Via Benzinga
7 Analysts Have This to Say About Globus Medical
Via Benzinga
What 5 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Wells Fargo Maintains Overweight Rating for Globus Medical: Here's What You Need To Know
Via Benzinga
Top 5 Health Care Stocks That Could Blast Off This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Globus Medical (GMED) Q3 2022 Earnings Call Transcript
GMED earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Analyst Ratings for Globus Medical
Within the last quarter, Globus Medical (NYSE:GMED) has observed the following analyst ratings: 
Via Benzinga
Expert Ratings for Globus Medical
Analysts have provided the following ratings for Globus Medical (NYSE:GMED) within the last quarter: 
Via Benzinga
Globus Medical-NuVasive Deal To Accelerate Globalization Strategy, Target $50B Musculoskeletal Market
Via Benzinga
GMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Globus Medical, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off another day of trading with a look at the biggest pre-market stock movers investors need to watch for Wednesday! 
Via InvestorPlace
Short Volatility Alert: Globus Medical, Inc.
On Thursday, shares of Globus Medical, Inc. (NYSE: GMED) experienced volatile short activity. After the activity, the stock price went up +1.83% to $62.78. The overall sentiment for GMED has been... 
Via Benzinga
Globus Medical Earnings Perspective: Return On Invested Capital
  
Via Benzinga
Analyst Ratings for Globus Medical
Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Globus Medical Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
2 Bear Market Stocks That Can Make You Richer in 2022 and Beyond
A bear market can present fresh opportunities for long-term investors. 
Via The Motley Fool
Globus Medical Reports Third Quarter 2022 Results
From Globus Medical
Via GlobeNewswire
Globus Medical's Earnings Outlook
Globus Medical (NYSE:GMED) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Globus Medical... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Globus Medical
Globus Medical (NYSE:GMED) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
Globus Medical's Return On Invested Capital Insights
Pulled from Benzinga Pro data, Globus Medical (NYSE:GMED) posted Q1 earnings of $38.08 million, an increase from Q4 of 152.11%. Sales dropped to $230.55 million, a 7.79% decrease between quarters. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.